Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Association of Community Cancer Centers and Advisory Board Launch 9th Annual Trends in Cancer Care Survey

      July 24, 2018
      By Association of Community Cancer Centers
      Article

      Survey to explore issues affecting care providers, patients, and programs.

      Building on the success of last year's collaboration, the Association of Community Cancer Centers (ACCC) and Advisory Board's Oncology Roundtable are again conducting a comprehensive survey that will explore how cancer programs across the country are moving forward and adapting in the midst of exciting, increasingly rapid advances in cancer care coupled with unprecedented change underway across the U.S. healthcare system. Funding and support for the "Trending Now in Cancer Care" survey is provided by Pfizer Oncology.

      "With a record number of respondents to last year's survey, ACCC is pleased to partner again with the Advisory Board's Oncology Roundtable to create this valuable snapshot focusing on how cancer programs are faring in today's healthcare environment," said Christian G. Downs, JD, MHA, ACCC Executive Director. "Our collaboration in conducting this trends survey brings the oncology community much-needed perspective on strengths and challenges of cancer programs in a health system that continues to struggle with transformation."

      The 2018 "Trending Now in Cancer Care" survey will address:

      • Staffing retention and turnover
      • Burnout and building resilience
      • Leveraging technology, including telehealth utilization, EHR interoperability
      • Treatment advances, including biomarker testing protocols
      • Familiarity with new immunotherapies, including CAR T-cell therapy
      • Multidisciplinary approaches to care
      • Challenges to clinical trial participation

      Findings will help cancer programs assess their strengths and areas for improvement, and plan strategically for the future. Survey participants will receive a customized report, comparing their program-type cohort data to national results.

      "This year's survey will help cancer programs identify strategies to ensure success in a changing healthcare environment," said Deirdre Saulet, PhD, Practice Manager for Oncology Roundtable at Advisory Board. "We are grateful for the opportunity to continue our partnership with ACCC on this survey."

      The "Trending Now in Cancer Care" survey is open to all oncology programs in the United States. Respondents do not need to be members of ACCC or Advisory Board to participate. Any members of the multidisciplinary cancer team, including cancer program executives and administrators, clinical staff, and physicians are invited to take the survey.

      Launched on July 9, 2018, the survey will be available online for approximately four weeks.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Related Content

      Enhancing Early-Stage NSCLC Care: Streamlining Biomarker Testing and Multidisciplinary Coordination Through Quality Improvement Initiatives

      Enhancing Early-Stage NSCLC Care: Streamlining Biomarker Testing and Multidisciplinary Coordination Through Quality Improvement Initiatives

      November 9th 2024
      Article

      Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure timely and effective biomarker testing for patients with early-stage NSCLC.


      Site Logo

      (C) Management, Inc.™ (CMI) Achieves AMC Institute Accreditation

      August 16th 2023
      Article

      (C) Management, Inc. (CMI), announced that is has recently been awarded accreditation by AMC Institute, the global trade association representing the Association Management industry.


      Site Logo

      ACCC Marks 15th Anniversary of Oncology Pharmacy Education Network

      Association of Community Cancer Centers
      October 22nd 2019
      Article

      ACCC is celebrating the 15th anniversary of Oncology Pharmacy Education Network by honoring its founders.


      Site Logo

      Association of Community Cancer Centers' Survey Finds Heavy Workloads and Workflow Inefficiencies are Top Concerns

      March 4th 2019
      Article


      Site Logo

      Association of Community Cancer Centers 2018 Survey Finds Multiple Barriers to Cancer Program Growth

      January 17th 2019
      Article

      Payer reimbursement requirements, uncertainties in reform policy, and cost of new treatments viewed as top threats.


      Site Logo

      Association of Community Cancer Centers Relaunches Immuno-Oncology Initiative to Meet Evolving Needs of Oncology Community

      November 30th 2018
      Article

      ACCC worked closely with a team of multispecialty thought leaders via the IO Institute Working Groups to develop forward-thinking resources at the intersection of clinical science, care delivery, business, operations, and policy to support all facets of immunotherapy integration.

      Related Content

      Enhancing Early-Stage NSCLC Care: Streamlining Biomarker Testing and Multidisciplinary Coordination Through Quality Improvement Initiatives

      Enhancing Early-Stage NSCLC Care: Streamlining Biomarker Testing and Multidisciplinary Coordination Through Quality Improvement Initiatives

      November 9th 2024
      Article

      Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure timely and effective biomarker testing for patients with early-stage NSCLC.


      Site Logo

      (C) Management, Inc.™ (CMI) Achieves AMC Institute Accreditation

      August 16th 2023
      Article

      (C) Management, Inc. (CMI), announced that is has recently been awarded accreditation by AMC Institute, the global trade association representing the Association Management industry.


      Site Logo

      ACCC Marks 15th Anniversary of Oncology Pharmacy Education Network

      Association of Community Cancer Centers
      October 22nd 2019
      Article

      ACCC is celebrating the 15th anniversary of Oncology Pharmacy Education Network by honoring its founders.


      Site Logo

      Association of Community Cancer Centers' Survey Finds Heavy Workloads and Workflow Inefficiencies are Top Concerns

      March 4th 2019
      Article


      Site Logo

      Association of Community Cancer Centers 2018 Survey Finds Multiple Barriers to Cancer Program Growth

      January 17th 2019
      Article

      Payer reimbursement requirements, uncertainties in reform policy, and cost of new treatments viewed as top threats.


      Site Logo

      Association of Community Cancer Centers Relaunches Immuno-Oncology Initiative to Meet Evolving Needs of Oncology Community

      November 30th 2018
      Article

      ACCC worked closely with a team of multispecialty thought leaders via the IO Institute Working Groups to develop forward-thinking resources at the intersection of clinical science, care delivery, business, operations, and policy to support all facets of immunotherapy integration.

      Latest Conference Coverage

      Relacorilant Combo Boosts PFS in Resistant Ovarian Cancer

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

      AI Tool May Predict Response, Resistance in Advanced RCC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.